European Journal of Nuclear Medicine

, Volume 4, Issue 3, pp 211–215 | Cite as

Uptake of67Ga-6-mercaptopurines in Morris hepatoma-3924 A

  • A. Guarino
  • S. K. Shukla
  • L. Castelli
  • C. Cipriani
  • G. B. Manni


67Ga-chloro-6-mercaptopurine and67Ga-citrato-6-mercaptopurine complexes have been prepared and their distribution in Morris-hepatoma-3924 A-bearing rats studied. The tumour affinity of the gallium-67 compounds varies in the order:67Ga-chloro-6-mercaptopurine > 67Ga-citrato-6-mercaptopurine > 67Ga-citrate > 67Ga-chloride.


Public Health Nuclear Medicine Tumour Affinity 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Bartosek, I., Donelli, M.G., Guaitani, A., Colombo, T., Russo, R., Garattini, S.: Differences of cyclophosphamide and 6-mercaptopurine metabolic rates in perfused liver of normal and tumour-bearing animals. Biochem. Pharmacol.24, 289–291 (1975)Google Scholar
  2. 2.
    Edwards, C.L., Hayes, R.L.: Scanning malignat neoplasms with gallium-67. J. Am. Med. Assoc.212, 1182–1190 (1970)Google Scholar
  3. 3.
    Goodwin, D.A., Meares, C.F.: Radiolabeled Antitumour Agents. Semin. Nucl. Med.6, 389–396 (1976)Google Scholar
  4. 4.
    Hart, M.M., Adamson, R.H.: Antitumour activity and toxicity of salts of inorganic group IIIa metals: aluminium, gallium, indium, and thallium. Proc. Nat. Acad. Sci. USA68, 1623–1626 (1971)Google Scholar
  5. 5.
    Hayakawa, T., Ushio, Y., Mogami, H., Horibata, K.: The uptake, distribution and antitumour activity of bleomycin in gliomas in the mouse. Europ. J. Cancer10, 137–142 (1974)Google Scholar
  6. 6.
    Hayes, R.L., Nelson, B., Swartzendruber, D.C., Carlton, J.E., Byrd, B.L.: Gallium-67 localization in rat and mouse tumours. Science167, 289–290 (1970)Google Scholar
  7. 7.
    Hayes, R.L.: The tissue distribution of gallium radionuclides. J. Nucl. Med.18, 740–742 (1977)Google Scholar
  8. 8.
    Hunt, F.C., Maddalena, D.J., Yeates, M.G.: Technetium-99m-6-mercaptupurine, a new radiopharmaceutical for cholescintigraphy. In: Recent advances in nuclear medicine. H. Ueda, M. Lio, S. Kato (eds.). Proceedings of the first world congress of nuclear medicine, Sept. 30–Oct. 5, 1974, pp. 869–871, Tokyo: Japan Radioisotopes Association 1974Google Scholar
  9. 9.
    Kaplan, H.S.: Hodgkin's disease: Multidisciplinary contributions to the conquest of a neoplasm. Radiology123, 551–558 (1977)Google Scholar
  10. 10.
    Kaufman, J.H., Cedermark, B.J., Parthasarathy, K.L., Didolkar, M.S., Bakshi, S.J.: The value of67Ga scintigraphy in soft-tissue sarcoma and chondrosarcoma. Radiology123, 131–134 (1977)Google Scholar
  11. 11.
    Kirschner, S., Wei, Y.K., Francis, D., Bergman, J.G.: Anticancer and potential antiviral activity of complex inorganic compounds. J. Med. Chem.9, 369–372 (1966)Google Scholar
  12. 12.
    Milch, R.A., Rall, D.P., Tobies, J.E.: Bone localization of tetracycline. J. Natl. Cancer Inst.19, 87–94 (1957)Google Scholar
  13. 13.
    Nouel, J.P., Renault, H., Robert, J., Jeanne, C., Wicart, L.: La bléomycine marquée au Co-57, Intérêt dans le diagnostic des tumeurs malignes et de leurs extension. Nouv. Presse Méd.1, 95–98 (1972)Google Scholar
  14. 14.
    Nouel, J.P., Robert, J., Bertrand, A., Witz, H., Delorme, G., Renault, H., Mamo, L.: Labelled bleomycin in the diagnosis of cancer: A study containing the results of 1,000 patients. In: Recent advances in nuclear medicine, H. Ueda, M. Lio, S. Kato (eds.). Proceedings of the first world congress of nuclear medicine, Sept. 30–Oct. 5, 1974, pp. 129–133. Tokyo: Japan Radioisotopes Association 1974Google Scholar
  15. 15.
    Pinsky, S.M., Henkin, R.E.: Gallium-67 tumour scanning. Semin. Nucl. Med.6, 397–409 (1976)Google Scholar
  16. 16.
    Rall, D.P., Loo, T.L., Lane, M., Kelly, M.G.: Appearance and persistance of fluorescent material in tumour tissue after tetracycline administration. J. Natl. Cancer Inst.19, 79–86 (1957)Google Scholar
  17. 17.
    Richman, S.D., Appelbaum, F., Levenson, S.M., Johnston, G.S., Ziegler, J.L.:67Ga radionuclide imaging in Burkitt's lymphoma. Radiology117, 639–645 (1975)Google Scholar
  18. 18.
    Shukla, S.K., Manni, G.B., Cipriani, C.: Behaviour of the pertechnetate ion in humans. J. Chromatogr.143, 522–526 (1977)Google Scholar
  19. 19.
    Shukla, S.K., Manni, G.B., Cipriani, C.: Effect of aluminium impurities in the generator-produced pertechnetate-99m ion on thyroid scintigrams. Eur. J. Nucl. Med.2, 137–141 (1977)Google Scholar
  20. 20.
    Silberstein, E.B.: The role of tumour imaging radiopharmaceuticals. Am. J. Med.60, 226–237 (1976)Google Scholar
  21. 21.
    Titus, E.D., Loo, T.L., Rall, D.P.: Identification of the bone fluorophore in tetracycline-treated rabbits. Antibiot. Ann., 949–953 (1957–1958)Google Scholar
  22. 22.
    Umezawa, H., Ishizuka, M., Mori, S., Chimura, H., Takeuchi, T.: The distribution of3Hbleomycin in mouse tissue. J. Antibiot.21, Ser. A, 638–642 (1968)Google Scholar
  23. 23.
    Umezawa, H., Takeuchi, T., Hori, S., Sawa, T., Ishizuka, M.: Studies on the mechanism of antitumour effect of bleomycin in squamous cell carcinoma. J. Antibiot.25, 409–420 (1972)Google Scholar
  24. 24.
    Watanabe, K., Kawashira, K., Kamoi, I., Morita, K., Matsura, K.: Clinical evaluation of57Co-bleomycin as a tumour localizing radiopharmaceutical: Its comparison with67Ga-citrate. In: Recent advances in nuclear medicine (H. Ueda, M. Lio, S. Kato, eds.). Proceedings of the first world congress of nuclear medicine. Sept. 30–Oct. 5, 1974, pp. 937–939. Tokyo: Japan Radioisotopes Association 1974Google Scholar

Copyright information

© Springer-Verlag 1979

Authors and Affiliations

  • A. Guarino
    • 1
  • S. K. Shukla
    • 1
  • L. Castelli
    • 2
  • C. Cipriani
    • 3
  • G. B. Manni
    • 3
  1. 1.Laboratorio di Chimica NucleareC.N.R.Monterotondo Stazione (Roma)Italy
  2. 2.Istituto Regina Elena per lo Studio e la Cura dei TumoriRomaItaly
  3. 3.Reparto di Medicina NucleareOspedale S. EugenioRomaItaly

Personalised recommendations